Michael Gelband’s Definitive Healthcare DH Stock Holding History

Michael Gelband’s Portfolio DH Stock Details DH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,360	Closed	-$47K	–	1667
2025 Q4	$47K	Buy	+16,360	New	+$45.4K	﹤0.01%	1455
2025 Q3	–	Sell	-72,241	Closed	-$282K	–	1643
2025 Q2	$282K	Buy	+72,241	New	+$228K	﹤0.01%	1251
2025 Q1	–	Sell	-92,076	Closed	-$378K	–	1575
2024 Q4	$378K	Buy	+92,076	New	+$403K	﹤0.01%	1220
2024 Q2	–	Sell	-125,974	Closed	-$1.02M	–	1619
2024 Q1	$1.02M	Buy	125,974 +55,431	+79%	+$490K	0.01%	938
2023 Q4	$701K	Sell	70,543 -300,853	-81%	-$2.36M	﹤0.01%	939
2023 Q3	$2.97M	Buy	371,396 +269,535	+265%	+$2.71M	0.03%	540
2023 Q2	$1.12M	Sell	101,861 -90,877	-47%	-$936K	0.01%	1056
2023 Q1	$1.99M	Buy	192,738 +130,263	+209%	+$1.53M	0.02%	876
2022 Q4	$687K	Buy	+62,475	New	+$803K	0.01%	1075

Other funds holding DH

Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Michael Gelband's DH Position: Q1 2026 in Review

Michael Gelband sold out of Definitive Healthcare (DH) in Q1 2026, closing a stake of 16,360 shares — an estimated $47K sold.

Michael Gelband first reported a position in DH in Q4 2022 and held it in 9 quarters. The position peaked at $2.97M in Q3 2023. 119 funds tracked by Wall St. Rank hold DH as of Q1 2026.

Michael Gelband reported no remaining Definitive Healthcare position as of Q1 2026 after selling out during the quarter.
Michael Gelband sold 16,360 Definitive Healthcare shares in Q1 2026, an estimated $47K.
Michael Gelband first reported a position in Definitive Healthcare in Q4 2022 and held it in 9 quarters.
Michael Gelband's Definitive Healthcare position peaked at $2.97M in Q3 2023.
119 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.